MMSI News & Events

Medtronic (MDT) announced that it has entered into a distribution agreement with Merit Medical Systems (MMSI), to offer FDA-cleared ViaVerte, a minimally invasive and implant free basivertebral nerve ablation system. It is the first and only BVNA system with a physician-controlled steerable mechanism for precise basivertebral nerve targeting for treating chronic vertebrogenic lower back pain. This agreement continues Medtronic's momentum in executing on strategic deals that strengthen the company's leadership within its core franchises and expands an ongoing relationship between Medtronic and Merit.

Merit Medical Systems announced the US commercial release of the Resilience Through-the-Scope Esophageal Stent. The Resilience stent is the newest product in Merit's Endoscopy portfolio, joining a comprehensive offering of treatment options for patients with disease in the esophagus. The new stent is indicated for treatment of esophageal fistulas and strictures caused by malignant tumors.